Trooperstocks
6 minutes ago
David Weinstein, Chief Executive Officer of Renovaro (Nasdaq: RENB) commented, “We believe this new capital now enables the company to accelerate our focus on revolutionizing healthcare by combining advanced diagnostic and personalized immunotherapy for early diagnosis, better-targeted treatments, a